Barron’s Take On The Remedy Adopted By CVS And Walgreen (CVS, WAG)

Walgreen WAG and the CVS Caremark Corporation CVS, two pharmacy store giants, recently announced a multi-year, mutual agreement, settling their June 7 quarrel and allowing the former to participate in CVS’s pharmacy benefit management. Teresa Rivas at Barron’s expressed that this step promises to benefit investors. She felt that this would clear the over-weighted Walgreen stock of any uncertainties. Rivas further stated that the common belief is that CVS would need to flatter Walgreen with prescription pricing concessions to benefit, but personally rebuffed such claims. Growth of same sale stores of CVS outpaced Walgreen's during the spat, as noted by The Wall Street Journal.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsConsumer StaplesDrug Retail
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!